Yi Sun

5.0k total citations · 1 hit paper
109 papers, 3.9k citations indexed

About

Yi Sun is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yi Sun has authored 109 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 21 papers in Oncology and 20 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yi Sun's work include Cancer-related molecular mechanisms research (10 papers), MicroRNA in disease regulation (9 papers) and Neonatal Respiratory Health Research (7 papers). Yi Sun is often cited by papers focused on Cancer-related molecular mechanisms research (10 papers), MicroRNA in disease regulation (9 papers) and Neonatal Respiratory Health Research (7 papers). Yi Sun collaborates with scholars based in China, United States and Malaysia. Yi Sun's co-authors include Chung S. Yang, Ming Zhu Fang, Ni Ai, William J. Welsh, Zhé Hóu, Hong Lu, Yimin Wang, Zhe Jin, Dapeng Chen and Judith K. Christman and has published in prestigious journals such as PLoS ONE, Cancer Research and Oncogene.

In The Last Decade

Yi Sun

105 papers receiving 3.8k citations

Hit Papers

Tea polyphenol (-)-epigallocatechin-3-gallate inhibits DN... 2003 2026 2010 2018 2003 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Tea polyphenol (-)-epigallocatechin-3-gallate inhibits DNA methyltransferase and reactivates methylation-silenced genes in cancer cell lines.
    2003 834 citations Yi Sun et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yi Sun China 30 2.0k 817 635 454 385 109 3.9k
Afsane Bahrami Iran 32 1.7k 0.9× 867 1.1× 600 0.9× 483 1.1× 322 0.8× 144 3.9k
Bing Liu China 27 1.7k 0.9× 1.0k 1.2× 409 0.6× 330 0.7× 292 0.8× 91 3.9k
Huihua Li United States 36 2.1k 1.1× 472 0.6× 683 1.1× 340 0.7× 454 1.2× 106 4.1k
Angela Lombardi Italy 35 2.1k 1.1× 1.1k 1.3× 476 0.7× 275 0.6× 346 0.9× 109 4.7k
Masato Maekawa Japan 33 1.6k 0.8× 565 0.7× 604 1.0× 469 1.0× 441 1.1× 222 3.9k
Yan Guo China 30 1.8k 0.9× 818 1.0× 536 0.8× 191 0.4× 279 0.7× 165 3.2k
Nan Song China 25 1.3k 0.6× 554 0.7× 760 1.2× 387 0.9× 292 0.8× 115 2.6k
Yan Li China 32 1.6k 0.8× 464 0.6× 688 1.1× 212 0.5× 487 1.3× 260 4.2k
Quancheng Kan China 35 2.5k 1.3× 1.2k 1.5× 515 0.8× 226 0.5× 355 0.9× 118 4.0k
Chia‐Jung Li Taiwan 32 1.6k 0.8× 646 0.8× 326 0.5× 338 0.7× 402 1.0× 130 4.0k

Countries citing papers authored by Yi Sun

Since Specialization
Citations

This map shows the geographic impact of Yi Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi Sun more than expected).

Fields of papers citing papers by Yi Sun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yi Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi Sun. The network helps show where Yi Sun may publish in the future.

Co-authorship network of co-authors of Yi Sun

This figure shows the co-authorship network connecting the top 25 collaborators of Yi Sun. A scholar is included among the top collaborators of Yi Sun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yi Sun. Yi Sun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Juan, Na Zhang, Wenjing Ren, et al.. (2025). Effect of chronic intermittent hypoxia on hippocampal lipid metabolism in mice: A targeted lipidomics study. Brain Research Bulletin. 224. 111319–111319.
2.
Li, Na, et al.. (2025). Berberine attenuates the expression of NLRP3 and downstream inflammasome effectors in diabetic retinopathy. Journal of Natural Medicines. 79(5). 1091–1105.
3.
Sun, Yi, Dandan Lin, Sijie Li, et al.. (2024). Interleukin-33 ameliorates perioperative neurocognitive disorders by modulating microglial state. Neuropharmacology. 253. 109982–109982. 5 indexed citations
4.
5.
Wang, Xiangyu, et al.. (2023). Utilization of clinical and radiological parameters to predict cognitive prognosis in patients with mild-to-moderate traumatic brain injury. Frontiers in Neuroscience. 17. 1222541–1222541. 2 indexed citations
6.
Zhao, Rongrong, Yi Sun, Qiang Wu, et al.. (2022). An Alternatively Spliced p62 Isoform Confers Resistance to Chemotherapy in Breast Cancer. Cancer Research. 82(21). 4001–4015. 14 indexed citations
7.
Huang, Xiao, et al.. (2021). Effect of Dexmedetomidine on Postoperative Sleep Quality: A Systematic Review. Drug Design Development and Therapy. Volume 15. 2161–2170. 42 indexed citations
8.
Yang, Jinsong, et al.. (2021). The role of microRNAs in regulating cadmium-induced apoptosis by targeting Bcl-2 in IEC-6 cells. Toxicology and Applied Pharmacology. 432. 115737–115737. 9 indexed citations
9.
Sun, Yi, et al.. (2021). Nonnegligible causes of symptoms of acute lower extremities——3 cases of May-Thurner syndrome with deep vein thrombosis. Thrombosis Journal. 19(1). 25–25. 4 indexed citations
10.
Sun, Yi, Xiaoxu Xie, Guo‐Bo Li, et al.. (2021). Knockdown of lncRNA ENST00000609755.1 Confers Protection Against Early oxLDL-Induced Coronary Heart Disease. Frontiers in Cardiovascular Medicine. 8. 650212–650212. 5 indexed citations
11.
Wang, Jing, et al.. (2021). The effect of intravenous ketamine on depressive symptoms after surgery: A systematic review. Journal of Clinical Anesthesia. 77. 110631–110631. 15 indexed citations
12.
Wang, Bian‐Rong, et al.. (2019). <p>Comparative diagnostic accuracy of ACE-III and MoCA for detecting mild cognitive impairment</p>. Neuropsychiatric Disease and Treatment. Volume 15. 2647–2653. 20 indexed citations
13.
Sun, Yi, et al.. (2017). Silibinin suppresses bladder cancer cell malignancy and chemoresistance in an NF-κB signal-dependent and signal-independent manner. International Journal of Oncology. 51(4). 1219–1226. 12 indexed citations
14.
Xiong, Yi-song, et al.. (2016). Inhibition of siglec-1 by lentivirus mediated small interfering RNA attenuates atherogenesis in apoE-deficient mice. Clinical Immunology. 174. 32–40. 18 indexed citations
15.
Chen, Sunxiao, Hongli Yan, Lei Zhang, et al.. (2015). Cryptococcus Neoformans Infection and Immune Cell Regulation in Human Monocytes. Cellular Physiology and Biochemistry. 37(2). 537–547. 12 indexed citations
16.
Hu, Zhide, Yan Chen, Lei Zhang, et al.. (2013). Red blood cell distribution width is a potential index to assess the disease activity of systemic lupus erythematosus. Clinica Chimica Acta. 425. 202–205. 73 indexed citations
17.
Jiang, Yiwen, et al.. (2012). Immunosuppression of NF-?B by intragastric brazilein in motor neuron of spinal cord connected with injured sciatic nerve in mouse. Biomedical Research-tokyo. 23(2). 0. 2 indexed citations
18.
Wang, Mei, Xuemei Li, Yi Sun, et al.. (2012). Mortality rates among prevalent hemodialysis patients in Beijing: a comparison with USRDS data. Nephrology Dialysis Transplantation. 28(3). 724–732. 43 indexed citations
19.
Zeng, Jin, Yi Sun, Kaijie Wu, et al.. (2011). Chemopreventive and Chemotherapeutic Effects of Intravesical Silibinin against Bladder Cancer by Acting on Mitochondria. Molecular Cancer Therapeutics. 10(1). 104–116. 63 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Afsane Bahrami Breakdown of academic impact, for papers by Bing Liu Breakdown of academic impact, for papers by Huihua Li Breakdown of academic impact, for papers by Angela Lombardi Breakdown of academic impact, for papers by Masato Maekawa Breakdown of academic impact, for papers by Yan Guo Breakdown of academic impact, for papers by Nan Song Breakdown of academic impact, for papers by Yan Li Breakdown of academic impact, for papers by Quancheng Kan Breakdown of academic impact, for papers by Chia‐Jung Li
Rankless by CCL
2026